Nagasaki University Hospital
Nagasaki Shi, Nagasaki, Japan
Medical office in Nagasaki
1 Chome-7-1 Sakamoto, Nagasaki, 852-8102
About Nagasaki University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
7
Boehringer Ingelheim
6
Galapagos NV
3
Janssen Pharmaceutical K.K.
3
Janssen Research & Development, LLC
3
Merck Sharp & Dohme LLC
3
Actelion
2
Daiichi Sankyo Co., Ltd.
2
Pfizer
2
Astex Pharmaceuticals, Inc.
1
Biogen
1
Clinical Trials at Nagasaki University Hospital
During the past decade, Nagasaki University Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 13 clinical trials were completed, i.e. on
average, 38.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
2005-11-01
2006-08-01
Completed
85
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
2007-07-01
2011-01-01
Completed
25
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
2008-04-01
2013-12-01
Completed
487
Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma
2008-05-01
Terminated
4
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
2010-09-16
2019-02-14
Completed
1,717
Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
2013-01-29
2021-05-28
Completed
666
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
2014-05-01
2016-05-01
Completed
647
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nagasaki University Hospital" #1 sponsor was "Amgen" with 7 trials, followed by "Boehringer Ingelheim" with 6 trials
sponsored, "Galapagos NV" with 3 trials sponsored, "Janssen Pharmaceutical K.K." with 3 trials sponsored and "Janssen Research & Development, LLC"
with 3 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nagasaki University Hospital"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Amgen Astellas Biopharma K.K." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Nagasaki University Hospital
According to Clinical.Site data, the most researched conditions in "Nagasaki University Hospital" are
"Prostatic Neoplasms" (4 trials), "Rheumatoid Arthritis" (3 trials), "Ulcerative Colitis" (3 trials), "Crohn's Disease" (2 trials) and "Dermatomyositis" (2 trials). Many other conditions were trialed in "Nagasaki University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Nagasaki University Hospital
Most popular intervention types in "Nagasaki University Hospital" are "Drug" (44 trials), "Biological" (5 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Enzalutamide" (4 trials), "Filgotinib" (4 trials), "Nintedanib" (3 trials) and "Pembrolizumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Nagasaki University Hospital
The vast majority of trials in "Nagasaki University Hospital" are
38 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Nagasaki University Hospital
Currently, there are NaN active trials in "Nagasaki University Hospital".
undefined are not yet recruiting,
12 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 16 completed trials in Nagasaki University Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Nagasaki University Hospital, 3 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".